All Stories

  1. Lecanemab
  2. Daprodustat
  3. Teplizumab
  4. Formulary Drug Reviews: Terlipressin
  5. Dasiglucagon
  6. Vericiguat
  7. Remdesivir
  8. Oliceridine
  9. Fostemsavir
  10. Meloxicam Intravenous Injection
  11. Cetirizine Hydrochloride Injection
  12. Lefamulin
  13. Risankizumab
  14. Formulary Drug Review: Sufentanil Sublingual
  15. Baloxavir Marboxil
  16. Omadacycline
  17. Coagulation Factor Xa (Recombinant), Inactivated-zhzo (Andexanet Alfa)
  18. Review of betrixaban
  19. Review of edaravone for ALS
  20. Review of etelcalcetide for secondary hyperparathyroidism
  21. Review of ocrelizumab for treatment of adult patients with relapsing or primary progressive MS
  22. Review of safinamide for treatment of Parkinson's disease with off episodes
  23. Naldemedine for treatment of opioid-induced constipation in adults with chronic noncancer pain
  24. Insulin Degludec/Liraglutide
  25. Eteplirsen
  26. Eteplirsen
  27. Bezlotoxumab
  28. Suvorexant
  29. Editorial on the problems associated with counterfeiting of medicine
  30. Emtricitabine
  31. Omalizumab
  32. The Pharmacy Preceptor: A Critical Link in Pharmacy Education
  33. Drug-Induced Renal Disorders
  34. Addressing Senior Audiences